COP vs UPB · P/E 19, rev $58.94B vs rev $2.4M
ConocoPhillips (COP) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. UPB currently screens at market cap $407.3M.
Not investment advice. Open the COP and UPB stock pages for the full models.
Not investment advice.